Global Medical REIT - GMRE Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" GMRE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GMRE, but not buy additional shares or sell existing shares.
View GMRE analyst ratings or view top-rated stocks.

3 brokerages have issued twelve-month target prices for Global Medical REIT's shares. Their GMRE share price forecasts range from $16.00 to $17.00. On average, they predict the company's stock price to reach $16.50 in the next year. This suggests a possible upside of 61.8% from the stock's current price.
View analysts price targets for GMRE or view top-rated stocks among Wall Street analysts.

Global Medical REIT's stock was trading at $17.75 at the start of the year. Since then, GMRE shares have decreased by 42.5% and is now trading at $10.20.
View the best growth stocks for 2022 here.

Global Medical REIT saw a decline in short interest in November. As of November 15th, there was short interest totaling 1,800,000 shares, a decline of 9.5% from the October 31st total of 1,990,000 shares. Based on an average trading volume of 681,500 shares, the short-interest ratio is presently 2.6 days. Approximately 11.8% of the company's stock are sold short.
View Global Medical REIT's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our GMRE earnings forecast.

Global Medical REIT Inc. (NYSE:GMRE) announced its earnings results on Wednesday, May, 4th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.23 by $0.19. Global Medical REIT had a trailing twelve-month return on equity of 3.76% and a net margin of 16.48%. During the same period in the prior year, the company posted $0.24 EPS.

Global Medical REIT announced a quarterly dividend on Friday, September 9th. Investors of record on Friday, September 23rd will be paid a dividend of $0.21 per share on Tuesday, October 11th. This represents a $0.84 annualized dividend and a yield of 8.24%. The ex-dividend date is Thursday, September 22nd.
Read our dividend analysis for GMRE.

Global Medical REIT (NYSE:GMRE) pays an annual dividend of $0.84 per share and currently has a dividend yield of 8.24%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 336.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, GMRE will have a dividend payout ratio of 89.36% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for GMRE.

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Block (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

(GMRE) raised $130 million in an initial public offering on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Global Medical REIT's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.67%), BlackRock Inc. (7.25%), State Street Corp (2.82%), Nuveen Asset Management LLC (2.72%), Brown Advisory Inc. (1.90%) and Royal Bank of Canada (1.88%). Insiders that own company stock include Henry Cole, Jeffrey Busch and Ronald Marston.
View institutional ownership trends.

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GMRE stock can currently be purchased for approximately $10.20.

Global Medical REIT (NYSE:GMRE) has a market capitalization of $668.30 million and generates $115.94 million in revenue each year. The company earns $17.62 million in net income (profit) each year or $0.25 on an earnings per share basis.

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The official website for the company is www.globalmedicalreit.com. The company can be reached via phone at (202) 524-6851 or via email at investors@globalmedicalreit.com.